Last update:
Weight management news
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
3 minutes ago
0
0
Common diet tips about water intake and spicy foods could be wrong
The common rationale for drinking water at meals is that it physically stretches the stomach, triggering fullness so you don't eat too much. But a new Cornell study found no support for that idea in practice. The paper is ...
4 hours ago
0
0
Rise of GLP-1s raises long-term affordability questions
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...
4 hours ago
0
0
What's driving the obesity pandemic?
New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15–17 July) asks what is driving the obesity pandemic.
6 hours ago
0
0
Ozempic-like drugs have more benefits to the body than just losing weight, meta-analysis shows
A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International Congress on Obesity (ICO 2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico ...
4 hours ago
0
0
Weight loss drugs could help with binge eating disorder
Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder in a new review of evidence led by University College London (UCL) researchers.
20 hours ago
0
5
Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World ...
Jul 15, 2026
0
7
Changing behavior to aid weight loss may be linked to reduced risks of obesity related cancers
A new systematic review and meta-analysis presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, July 15–17, is the first study to show that behavioral ...
Jul 15, 2026
0
3
Coca-Cola 'sportswashing' during World Cup amplified by social media
New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (July 15–17), reveals how Coca-Cola's sponsorship of the 2025 FIFA Club ...
Jul 15, 2026
0
3
Muscles matter for diabetes risk, new study finds
A major new international study led by Curtin University has found diabetes risk is about more than body weight or obesity, revealing that muscle health also likely plays a major role in whether people develop the condition.
Jul 14, 2026
0
10
Why food skills belong in the school curriculum—not left to chance at home
One in 10 children ages 7 to 9 is living with obesity in Europe. In England, childhood obesity rises from around 10% of children in Reception to around 22% by Year 6. While we know there are many complex and inter-connected ...
Jul 14, 2026
0
3
The GLP‑1 disclosure dilemma: Should you tell a date you're using Ozempic for weight loss?
As a Gen Xer who lived through the "heroin chic" years, when skeletal models were celebrated for jutting bones and sallow skin, the recent popularity of the #Y2KSkinny trend fills me with dread.
Jul 14, 2026
0
2
Study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop it
Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help patients facing aggressive blood cancers overcome this metabolic risk, researchers identified a potential ...
Jul 13, 2026
0
6
Study shows promising outcomes for bariatric surgery in adolescents and young adults with severe obesity
A new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute demonstrates that metabolic and bariatric surgery can be delivered ...
Jul 13, 2026
0
2
Knowledge about genes isn't enough: How to inform people about genetic risk of obesity
Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study published in the journal Obesity Reviews by scientists, including researchers from SWPS University, shows ...
Jul 13, 2026
0
1
Night owls eat later, choose less nutritious food, carry more belly fat and show higher metabolic risk
For generations, early to bed and early to rise was seen as the blueprint for a healthy life, and any departure from it was often considered unhealthy. Scientists, however, have discovered that whether someone is an early ...
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to ...
Jul 11, 2026
0
800
Weight‑loss jabs may create a new kind of yo‑yo dieting
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after ...
Jul 10, 2026
0
6
New treatment helps achieve a healthier BMI in people with weight dysregulation after brain tumors
A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England ...
Jul 9, 2026
0
3
Researchers uncover hormone link between gut and brain in anorexia nervosa
People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute phase of the disorder, according to research presented at the Federation of European Neuroscience ...
Jul 9, 2026
0
4
GLP-1 use hits record high as Medicare opens access to weight-loss drugs
The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.
Jul 9, 2026
0
13
Societies combine to issue recommendations on use of incretin drugs in obesity therapy
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes ...
Jul 9, 2026
0
5
Medicare prescriptions for Wegovy jumped after approval for heart disease
Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the treatment, according ...
Jul 9, 2026
0
5
Most obesity drugs do not improve quality of life or heart health, analysis indicates
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence ...
Jul 8, 2026
0
66
Race and ethnicity modify the association between US socioeconomic status and metabolic disease
Higher socioeconomic status is not associated with equal reductions in rates of type 2 diabetes and obesity across all racial and ethnic groups in the United States, according to a new study published July 8, 2026, in the ...
Jul 8, 2026
0
4
